Page last updated: 2024-08-23

dihydro-beta-erythroidine and Schizophrenia

dihydro-beta-erythroidine has been researched along with Schizophrenia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Yavas, E; Young, AMJ1
Freedman, R; Simosky, JK; Stevens, KE1
Bitner, RS; Bratcher, NA; Decker, MW; Gopalakrishnan, M; Miner, HM; Radek, RJ1

Other Studies

3 other study(ies) available for dihydro-beta-erythroidine and Schizophrenia

ArticleYear
Repeated phencyclidine disrupts nicotinic acetylcholine regulation of dopamine release in nucleus accumbens: Implications for models of schizophrenia.
    Neurochemistry international, 2020, Volume: 140

    Topics: Animals; Dihydro-beta-Erythroidine; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Nucleus Accumbens; Phencyclidine; Rats; Rats, Wistar; Receptors, Nicotinic; Schizophrenia

2020
Olanzapine improves deficient sensory inhibition in DBA/2 mice.
    Brain research, 2008, Oct-03, Volume: 1233

    Topics: Acoustic Stimulation; Analysis of Variance; Animals; Antipsychotic Agents; Attention; Auditory Perceptual Disorders; Benzodiazepines; Bungarotoxins; Conditioning, Classical; Dihydro-beta-Erythroidine; Disease Models, Animal; Drug Interactions; Evoked Potentials, Auditory; Field Dependence-Independence; Inhibition, Psychological; Male; Mice; Mice, Inbred DBA; Nicotinic Antagonists; Olanzapine; Schizophrenia; Statistics, Nonparametric

2008
Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating.
    Psychopharmacology, 2006, Volume: 187, Issue:1

    Topics: Animals; Dihydro-beta-Erythroidine; Dose-Response Relationship, Drug; Evoked Potentials, Auditory; Hippocampus; Mecamylamine; Mental Processes; Mice; Mice, Inbred DBA; Nicotine; Receptors, Nicotinic; Schizophrenia

2006